Latest filing: trade of 19 Jan 2026 for BIRZEIT PHARMACEUTICALS. The register gives no publication date.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
لوتس للاستثمارات المالية: trading record in brief
لوتس للاستثمارات المالية discloses dealings in Birzeit Pharmaceuticals to PCMA / Palestine Exchange. Over a trading history stretching from 9 October 2025 to 19 January 2026, the count stands at 7 filings.
In open-market terms, that means 5 purchases on one side and 2 sales on the other. The totals exclude 7 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 2 purchases and no sales.
The newest entry dates from 19 January 2026: an open-market purchase, in Birzeit Pharmaceuticals. These figures are compiled from regulatory filings published by PCMA / Palestine Exchange. They describe what insiders did and are not a recommendation.
Companies and markets linked to لوتس للاستثمارات المالية
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,100 sharesSharePEXPEX:5ed8c895c506-1Canonical exit: 19 Apr 2026 (T+90)
- 100 sharesSharePEXPEX:bcff85db3091-1Canonical exit: 6 Apr 2026 (T+90)
- 15,000 sharesSharePEXPEX:fd29b654de9f-1Canonical exit: 31 Mar 2026 (T+90)
- 600 sharesSharePEXPEX:02fc210ab2fa-1
- 52,400 sharesSharePEXPEX:b60c6ff29f73-1
- 600 sharesSharePEXPEX:051b39ed598a-1Canonical exit: 4 Feb 2026 (T+90)
- 1,200 sharesSharePEXPEX:46ff17a458a6-1Canonical exit: 7 Jan 2026 (T+90)
7 of 7 declarations